Brief: Virpax Pharmaceuticals Files Provisional Patent Application For Intranasal Delivery
13/07/2023 13:58
Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS FILES PROVISIONAL PATENT
APPLICATION FOR
INTRANASAL DELIVERY
Source text for Eikon: ID:nBw1JY3Jva
Further company coverage: VRPX.O
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study